Overview

Naltrexone in the Treatment of Trichotillomania

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago
Treatments:
Naltrexone